Showing results (291-300 of 2,599) with videos related to
Sort By:
Pageof 260
Prostaglandins|December 1, 1984
Identification of leukotriene D4 specific binding sites in the membrane preparation isolated from guinea pig lungS Mong, H L Wu, M A Clark, et al.Cancer Research|December 1, 1981
Inhibition of bleomycin-induced DNA breakage by superoxide dismutaseL Galvan, C H Huang, A W Prestayko, et al.Receptor|January 1, 1991
Regulation of topoisomerase I and II activities by cyclic nucleotide- and phospholipid-dependent protein kinases. Effects of interactions between the two transduction pathwaysM R Mattern, P Nambi, J O Bartus, et al.Cancer Treatment Reports|December 1, 1977
Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolusS T Crooke, R L Comis, L H Einhorn, et al.Molecular Pharmacology|January 1, 1987
Induction of metallothionein is correlated with resistance to auranofin, a gold compound, in Chinese hamster ovary cellsB P Monia, T R Butt, C K Mirabelli, et al.The Journal of Laboratory and Clinical Medicine|December 1, 1990
Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivoJ S Bomalaski, M Fallon, R A Turner, et al.Molecular and Cellular Biology|August 1, 1994
Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutantD Finley, S Sadis, B P Monia, et al.Life Sciences|July 23, 1984
Leukotriene C4 ([3H]-LTC4) binding to membranes isolated from a hamster smooth muscle cell line (DDT1MF2)M A Clark, M Cook, S Mong, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to ratsP A Cossum, L Truong, S R Owens, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 1991
Cloning of a phospholipase A2-activating proteinM A Clark, L E Ozgür, T M Conway, et al.Pageof 260